FDA's Proposed GTP Rule Requires Tracking Of Tissue Combination Devices
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of devices that incorporate human cells or tissue will be required to track their products under a "current Good Tissue Practices" proposed rule published in the Federal Register Jan. 8.
You may also be interested in...
CryoLife Reviewing Tissue Sterilization Process In Wake Of Warning Letter
FDA is increasing its scrutiny over validation of tissue processing practices, as evidenced by a June 17 warning letter to CryoLife
CryoLife Reviewing Tissue Sterilization Process In Wake Of Warning Letter
FDA is increasing its scrutiny over validation of tissue processing practices, as evidenced by a June 17 warning letter to CryoLife
EU Tissue Product Approval Should Be Distinct From Devices - EC Cmte.
Approval and regulation of tissue-engineered products should be separate from the current procedures for medical devices, according to the European Commission's Scientific Committee on Medicinal Products and Medical Devices.